
USA - NASDAQ:LNDC - US5147661046 - Common Stock
The current stock price of LNDC is 8.76 USD. In the past month the price increased by 5.8%. In the past year, price decreased by -7.69%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MDLZ | MONDELEZ INTERNATIONAL INC-A | 19.99 | 73.72B | ||
| HSY | HERSHEY CO/THE | 24.44 | 36.11B | ||
| KHC | KRAFT HEINZ CO/THE | 9.04 | 29.54B | ||
| K | KELLANOVA | 22.51 | 28.98B | ||
| GIS | GENERAL MILLS INC | 11.83 | 25.25B | ||
| TSN | TYSON FOODS INC-CL A | 13.18 | 19.32B | ||
| MKC | MCCORMICK & CO-NON VTG SHRS | 22.48 | 17.74B | ||
| MKC.V | MCCORMICK & CO INC VTG COM | 22.35 | 17.64B | ||
| HRL | HORMEL FOODS CORP | 15.41 | 12.46B | ||
| SJM | JM SMUCKER CO/THE | 11.51 | 11.77B | ||
| CPB | THE CAMPBELL'S COMPANY | 10.48 | 9.30B | ||
| PPC | PILGRIM'S PRIDE CORP | 6.4 | 8.94B |
Landec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Santa Maria, California and currently employs 689 full-time employees. The company designs, develops, manufactures, and sells differentiated products for biomaterials and food markets, and license technology applications to partners. Its business segments include Lifecore and Curation Foods. Its Landec’s Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, fill and finish of sterile, injectable pharmaceutical products in syringes and vials. Its services include technology development, material component changes, analytical method development, formulation development. Its Curation Foods is focused on distributing plant-based foods with clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods brands include O Olive Oil & Vinegar, Yucatan, and Cabo Fresh.
LANDEC CORP
2811 Airpark Drive
Santa Maria CALIFORNIA 93455 US
CEO: Albert D. Bolles
Employees: 689
Phone: 16503061650.0
Landec Corp. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Santa Maria, California and currently employs 689 full-time employees. The company designs, develops, manufactures, and sells differentiated products for biomaterials and food markets, and license technology applications to partners. Its business segments include Lifecore and Curation Foods. Its Landec’s Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, fill and finish of sterile, injectable pharmaceutical products in syringes and vials. Its services include technology development, material component changes, analytical method development, formulation development. Its Curation Foods is focused on distributing plant-based foods with clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods brands include O Olive Oil & Vinegar, Yucatan, and Cabo Fresh.
The current stock price of LNDC is 8.76 USD. The price decreased by -3.52% in the last trading session.
LNDC does not pay a dividend.
LNDC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
LANDEC CORP (LNDC) operates in the Consumer Staples sector and the Food Products industry.
LANDEC CORP (LNDC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.36).
LANDEC CORP (LNDC) currently has 689 employees.
ChartMill assigns a technical rating of 1 / 10 to LNDC. When comparing the yearly performance of all stocks, LNDC is a bad performer in the overall market: 60% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to LNDC. Both the profitability and financial health of LNDC have multiple concerns.
Over the last trailing twelve months LNDC reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS decreased by -56.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -47.78% | ||
| ROA | -38.31% | ||
| ROE | N/A | ||
| Debt/Equity | 0.99 |
10 analysts have analysed LNDC and the average price target is 14.03 USD. This implies a price increase of 60.1% is expected in the next year compared to the current price of 8.76.
For the next year, analysts expect an EPS growth of -7.67% and a revenue growth 9.57% for LNDC